Unisom Use in Pregnancy is Safe
Yes, Unisom is safe to use during pregnancy—both formulations (doxylamine succinate and diphenhydramine) are considered acceptable, though doxylamine is preferred as a first-line option based on current guidelines. 1, 2
Doxylamine Succinate (Preferred Unisom Formulation)
The American College of Obstetricians and Gynecologists (ACOG) recommends doxylamine as a safe first-line pharmacologic treatment for nausea and vomiting in pregnancy when non-pharmacologic measures fail. 1 This is the most strongly endorsed formulation:
- Doxylamine is FDA-approved specifically for treating nausea and vomiting of pregnancy, particularly in combination with pyridoxine (vitamin B6). 1
- Large birth registries, case-control studies, and cohort studies have confirmed the safety of first-generation antihistamines including doxylamine during the first trimester, with no significant increase in congenital malformations. 1
- A randomized placebo-controlled trial demonstrated that doxylamine succinate 10 mg (up to 4 tablets daily) is safe and well-tolerated by pregnant women, with no increased rate of adverse events compared to placebo. 3
Diphenhydramine (Alternative Unisom Formulation)
Diphenhydramine carries slightly more caution but remains acceptable:
- Diphenhydramine has been associated with an increased risk of cleft palate development in some studies; therefore, dimenhydrinate or doxylamine are preferred when an antihistamine is needed. 2
- However, older safety data from 1986 suggest that the risks of using diphenhydramine appear to be low overall. 4
- The FDA label advises pregnant women to "ask a healthcare professional before use" but does not contraindicate its use. 5
Treatment Algorithm for Pregnancy-Related Symptoms
When managing nausea, vomiting, or sleep disturbances in pregnancy, follow this stepwise approach:
Step 1: Non-pharmacologic measures first 1
- Dietary modifications (small, frequent, bland meals)
- Avoidance of triggers
- Ginger 250 mg four times daily
- Pyridoxine (vitamin B6) 10-25 mg every 8 hours
Step 2: First-line pharmacologic options if symptoms persist 1, 2
- Doxylamine (preferred Unisom formulation)
- Dimenhydrinate
- Promethazine
Step 3: Second-line options for inadequate response 1
- Metoclopramide (similar efficacy to promethazine but fewer adverse events such as drowsiness)
Step 4: Severe cases requiring hospitalization 1
- Ondansetron or methylprednisolone on a case-by-case basis
Critical Safety Considerations
- The most critical period for concern about congenital malformations is the first trimester during organogenesis, though both doxylamine and diphenhydramine have demonstrated acceptable safety profiles during this period. 1
- Both formulations cause marked drowsiness; patients should avoid driving, operating machinery, and consuming alcohol. 6, 5
- The FDA labels for both formulations state "if pregnant or breast-feeding, ask a health professional before use," which reflects standard precautionary language rather than a contraindication. 6, 5
Common Pitfalls to Avoid
- Do not confuse Unisom with oral decongestants (phenylephrine, pseudoephedrine), which should be avoided during the first trimester due to associations with gastroschisis and small intestinal atresia. 7, 2
- Avoid using diphenhydramine with any other product containing diphenhydramine to prevent overdose. 5
- Do not use doxylamine with any other product containing doxylamine. 6
- Monitor for rare but serious adverse effects in overdose situations, such as syndrome of inappropriate antidiuresis (SIAD) with severe hyponatremia. 8
Bottom Line for Clinical Practice
Choose doxylamine succinate (Unisom SleepTabs) as the preferred formulation based on ACOG guidelines and FDA approval for pregnancy-related nausea. 1 If only diphenhydramine (Unisom SleepGels/SleepMelts) is available, it remains a reasonable option with slightly more caution regarding cleft palate risk. 2, 4 Both are vastly safer than untreated severe nausea and vomiting, which can lead to dehydration, electrolyte imbalances, and nutritional deficiencies. 1